NRG-CC013

Who Can Participate?

Age Range

18-110

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

Locations

Duke University Hospital

Visit Timing

Weekdays

Compensation

No

Spanish Materials Available

Yes

Study Details

Full Title

NRG-CC013: A RANDOMIZED, MASKED, PLACEBO CONTROLLED, PHASE II TRIAL OF CONCURRENT CHEMORADIATION WITH BMX-001 IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CHEMORADIATION

Principal Investigator

Jared
Robbins

Protocol Number

PRO00117671

NCT ID

NCT06532279

Phase

II

Enrollment Status

Open to Enrollment